G Onal, G Yalçın-Çakmaklı, C E Özçelik, I Boussaad, U Ö Ş Şeker, Hugo J R Fernandes, H Demir, R Krüger, B Elibol, S Dökmeci, M M Salman
Glucocerebrosidase 1 (GBA1) mutations are the most important genetic risk factors for Parkinson's disease (PD). Clinically, mild (e.g., p.N370S) and severe (e.g., p.L444P and p.D409H) GBA1 mutations have different PD phenotypes, with differences in age at disease onset, progression, and the severity of motor and non-motor symptoms. We hypothesize that GBA1 mutations cause the accumulation of α-synuclein by affecting the cross-talk between cellular protein degradation mechanisms, leading to neurodegeneration...
April 20, 2024: Journal of Neurochemistry